Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -17.343% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
(a) COc1ccc(CCC(=O)Nc2nc3ccccc3[nH]2)cc1OC
(b) CC(C)c1ccc(/C=C2\SC(=S)N(CCC(=O)NCCCn3ccnc3)C2=O)cc1
(c) OCC1(CCOc2ccccc2)CCN(Cc2ccccc2C(F)(F)F)CC1
(d) CC(=O)c1cccc(NC(=O)c2cc(-c3ccc(C)cc3)on2)c1
(e) COc1cc(CNCCO)cc(Cl)c1OCc1ccccc1Cl.Cl
Answer: b. CC(C)c1ccc(/C=C2\SC(=S)N(CCC(=O)NCCCn3ccnc3)C2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)c1ccc(/C=C2\SC(=S)N(CCC(=O)NCCCn3ccnc3)C2=O)cc1
CC(C)c1ccc(/C=C2\SC(=S)N(CCC(=O)NCCCn3ccnc3)C2=O)cc1
N-(3-imidazol-1-ylpropyl)-3-[(5Z)-4-oxo-5-[(4-propan-2-ylphenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]propanamide